UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039139
Receipt number R000044642
Scientific Title Acute garlic supplementation ameliorates exercise-induced lipid peroxidation in sedentary individuals
Date of disclosure of the study information 2020/01/13
Last modified on 2020/01/13 21:43:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Acute garlic supplementation ameliorates exercise-induced lipid peroxidation in sedentary individuals

Acronym

Acute garlic supplementation

Scientific Title

Acute garlic supplementation ameliorates exercise-induced lipid peroxidation in sedentary individuals

Scientific Title:Acronym

Acute garlic supplementation ameliorates exercise-induced lipid peroxidation in sedentary individuals

Region

Asia(except Japan)


Condition

Condition

exercise-induced oxidative stress

Classification by specialty

Medicine in general Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

The aim of the present study was to determine the acute effect of garlic supplementation on total antioxidant capacity and some markers of exercise-induced oxidative stress in sedentary individuals.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Total antioxidant capacity (TAC)
Malondialdehyde (MDA)
Creatine kinase (CK)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Consumed supplement (1000 mg allicin, Nature made, USA)

Interventions/Control_2

Placebo (starch) with plain water

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

30 years-old >=

Gender

Male

Key inclusion criteria

Healthy state
age range of 20-30 yrs
inactive life-style according to physical activity assessment

Key exclusion criteria

tobacco use
medicine and supplement intake
non-smoker
not taking any medication or supplements

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Aynollah
Middle name
Last name Naderi

Organization

Shahrood University of Technology

Division name

Sport science

Zip code

3619995161

Address

Semnan Province, Shahroud

TEL

02332392204

Email

ay.naderi@shahroodut.ac.ir


Public contact

Name of contact person

1st name Aynollah
Middle name
Last name Naderi

Organization

Shahrood University of Technology

Division name

Sport science

Zip code

3619995161

Address

Semnan Province, Shahroud

TEL

02332392204

Homepage URL


Email

ay.naderi@shahroodut.ac.ir


Sponsor or person

Institute

Shahrood University of Technology

Institute

Department

Personal name



Funding Source

Organization

Shahrood University of Technology

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shahrood University of Technology

Address

Semnan Province, Shahroud

Tel

02332392204

Email

ay.naderi@shahroodut.ac.ir


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 13 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 04 Month 03 Day

Date of IRB

2020 Year 01 Month 01 Day

Anticipated trial start date

2019 Year 06 Month 01 Day

Last follow-up date

2019 Year 11 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 01 Month 13 Day

Last modified on

2020 Year 01 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044642